Amaratunga K, Tarasuk J, Tsegaye L, Archibald C P
Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
The Ottawa Hospital and University of Ottawa, Department of Medicine, Division of Infectious Diseases, Ottawa, ON.
Can Commun Dis Rep. 2016 Nov 3;42(11):232-237. doi: 10.14745/ccdr.v42i11a03.
Antimicrobials are essential for the treatment and control of infectious diseases and therefore, the development and spread of antimicrobial resistance (AMR) is a global health concern. It is recognized that robust AMR surveillance is necessary; however, current gaps in national surveillance programs need to be addressed to enable better evidence-informed program and policy decisions.
To describe how an AMR Surveillance Task Group prioritized national AMR surveillance data requirements for high priority AMR organisms for human health in Canada and made recommendations on addressing the current data gaps.
The 2015 AMR Surveillance Task Group examined the data requirements for previously identified first priority organisms and assessed whether the current system met, partially met or did not meet these requirements. Information was summarized into synopsis tables and a ranking process was used to prioritize the data requirements and develop specific recommendations to address the gaps.
First priority organisms identified for AMR surveillance are: , Extended-spectrum β-lactamase-producing organisms, Carbapenem-resistant organisms ( + Enterobacteriaceae species), species, , and , species, , and species. For these organisms, there were 19 high priority data requirements identified: 10 of these requirements were met by the current surveillance systems, seven were partially met and two were unmet. For the two high priority data metrics in the community setting, the Task Group recommended conducting a point-prevalence community-based study (i.e., every five years) to follow infection rates of infection, and community level antibiogram data on an annual basis for susceptibility data for Enterobacteriaceae species ( and ) causing genito-urinary infections. There were eight medium priority data requirements identified: one requirement was met by the current surveillance system, five were partially met and two were unmet. The medium priority unmet data requirements included susceptibility of infection isolates for (diarrheal disease) and infection rates for Enterobacteriaceae species causing genito-urinary tract infections in community settings. It was noted that the feasibility of obtaining this medium priority in data in the community setting was low. The Task Group identified bloodstream infections as the top priority site of infection for AMR surveillance in the health care setting given the high morbidity and mortality associated with bloodstream infections. The importance of collecting susceptibility data on in the community was underscored given the rise in resistance and that the current surveillance system only partially collects this data. The Task Group recommended that a review of the national AMR surveillance data requirement priorities should occur on an ongoing basis and when new issues emerge.
While current national surveillance programs either capture or partially capture many of the identified data requirements for first priority organisms, several gaps still remain, especially in community settings. A national review of the recommendations of the Task Group is underway.
抗菌药物对于传染病的治疗和控制至关重要,因此,抗菌药物耐药性(AMR)的发展和传播是一个全球卫生问题。人们认识到,强有力的AMR监测是必要的;然而,需要解决国家监测计划目前存在的差距,以便能够做出更有依据的计划和政策决策。
描述一个AMR监测任务组如何确定加拿大人类健康高优先级AMR病原体的国家AMR监测数据要求,并就解决当前数据差距提出建议。
2015年AMR监测任务组审查了先前确定的首要病原体的数据要求,并评估了当前系统是否满足、部分满足或未满足这些要求。信息被汇总到概要表中,并采用排名程序确定数据要求的优先级,并制定解决差距的具体建议。
确定用于AMR监测的首要病原体为:产超广谱β-内酰胺酶的生物体、耐碳青霉烯类生物体(+肠杆菌科菌种)、菌种、、和、菌种、、和菌种。对于这些生物体,确定了19项高优先级数据要求:其中10项要求由当前监测系统满足,7项部分满足,2项未满足。对于社区环境中的两项高优先级数据指标,任务组建议开展一项基于社区的现患率研究(即每五年一次),以跟踪感染率,以及每年收集社区层面关于引起泌尿生殖道感染的肠杆菌科菌种(和)药敏数据的抗菌谱数据。确定了8项中优先级数据要求:1项要求由当前监测系统满足,5项部分满足,2项未满足。中优先级未满足的数据要求包括感染分离株对(腹泻病)的药敏性以及社区环境中引起泌尿生殖道感染的肠杆菌科菌种的感染率。需要指出在社区环境中获取这些中优先级数据的可行性较低。鉴于血流感染相关的高发病率和高死亡率,任务组将血流感染确定为医疗保健环境中AMR监测的首要感染部位。鉴于耐药性上升且当前监测系统仅部分收集该数据,强调了在社区收集药敏数据的重要性。任务组建议应持续且在出现新问题时对国家AMR监测数据要求的优先级进行审查。
虽然当前国家监测计划要么捕获要么部分捕获了许多已确定的首要病原体的数据要求,但仍存在一些差距,尤其是在社区环境中。目前正在对任务组的建议进行全国性审查。